Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)
- Status
- COMPLETED
- Phase
- PHASE3
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
- Status
- COMPLETED
- Phase
- PHASE4
Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
- Status
- TERMINATED
- Phase
- PHASE3
Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
- Status
- COMPLETED
- Phase
- PHASE3
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)
- Status
- COMPLETED
- Phase
- PHASE4
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)
- Status
- COMPLETED
- Phase
- PHASE3